Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Daniel, Herchenhorn"'
Autor:
Helena Ferreira Bruzzi Porto, Gabriela C.K. Lopes, Hannah B.V. Bekierman, Sérgio Altino De Almeida, Felipe Da Matta Andreiuolo, Evandro Lucena, Sandip Pravin Patel, Vinicius Freire, Daniel Herchenhorn
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 950-959 (2024)
Introduction: High-grade treatment-emergent neuroendocrine prostate cancer (T-NEPC) is a rare subtype of prostate cancer with limited therapeutic options and poor prognosis. Understanding biomarkers that influence the efficacy of immune checkpoint in
Externí odkaz:
https://doaj.org/article/022c03ad380b48dd8020392e75ffeda3
Autor:
Fabiana Hottz, Daniel Herchenhorn, Juliana Lenzi, Juliana Andrade, Vinicius Freire, Pedro Pinho
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-5 (2022)
Abstract In-field dermatitis is a severe and common adverse effect of radiation therapy, that can cause significant pain and treatment interruptions in patients with squamous cell anal carcinoma (SCAC) being treated with radical chemoradiation protoc
Externí odkaz:
https://doaj.org/article/e5b114ba9cae48f6b000f6ace0a4a631
Autor:
Fernando Cotait Maluf, Felipe Moraes Toledo Pereira, Adriano Gonçalves Silva, Aldo Lourenço Abbade Dettino, Ana Paula Garcia Cardoso, André Seeke Sasse, Andrey Soares, Ariel Galapo Kann, Daniel Herchenhorn, Denis Leonardo Fontes Jardim, Diego Emilio Lopera Cortés, Fábio Roberto Kater, Igor A. Protzner Morbeck, João Francisco Navarro Reolon, José Augusto Rinck Jr, Juan Jose Zarbá, Juan Pablo Sade, Karine Martins da Trindade, Leonardo Atem G. A. Costa, Lucas V. dos Santos, Manuel Caitano Maia, Mariana Bruno Siqueira, Silke Gillessen
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 559-571 (2021)
PURPOSETo present a summary of the recommendations for the treatment and follow-up for metastatic castration-resistant prostate cancer (mCRPC) as acquired through a questionnaire administered to 99 physicians working in the field of prostate cancer i
Externí odkaz:
https://doaj.org/article/4d68337d7f2e42769e733ed66d73f3bc
Autor:
Felipe Moraes Toledo Pereira, Adriano Gonçalves e Silva, Aldo Lourenço Abbade Dettino, Ana Paula Garcia Cardoso, Andre Deeke Sasse, Ariel Galapo Kann, Carlos Dzik, Daniel Herchenhorn, Denis Leonardo Fontes Jardim, Diego Lopera, Mouna Ayadi, Pamela Salman, Ray Antonio Manneh Kopp, Ricardo Saraiva De Carvalho, Sandro Roberto De Araujo Cavallero, Sergio Aguiar, Vinicius Carrera Souza, Pedro Luiz Serrano Uson Junior, Andrey Soares
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 545-549 (2021)
PURPOSETo present a summary of the recommendations for the treatment and follow-up for the biochemical recurrence of castration-resistant prostate cancer (PCa) as acquired through a questionnaire administered at the Prostate Cancer Consensus Conferen
Externí odkaz:
https://doaj.org/article/bbdaea0ebdd646088cb58620ddcd66b8
Autor:
Daniel Herchenhorn, Lídia Magalhães Rezende, Luiz Cláudio Thuler, Raquel C. Maia, Morvan Medina, Mário Alberto Dantas da Costa
Publikováno v:
Revista Brasileira de Cancerologia, Vol 46, Iss 2 (2022)
A quimioterapia é tratamento padrão inicial para câncer de mama localmente avançado. A correlação entre a resposta à quimioterapia neoadjuvante e fatores prognósticos pode ser útil nesta doença. De setembro 1996 a dezembro de 1997, 25 pacie
Externí odkaz:
https://doaj.org/article/ad4ee530aa184e8fad6234037ee2605e
Autor:
Natalia Treistman, Gabriela Maia Nobre, Mariana Yoshii Tramontin, Gabriel Madeira Werberich da Silva, Daniel Herchenhorn, Luiz Henrique de Lima Araujo, Fernanda Accioly de Andrade, Rossana Corbo, Daniel Bulzico, Fernanda Vaisman
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 65, Iss 4, Pp 411-420 (2021)
ABSTRACT Objective: The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced differentiated thyroid carcinoma (DTC) refractory to radioactive iodine (RAIR) therapy. Subjects and methods: W
Externí odkaz:
https://doaj.org/article/3cfdaac2acec4bffa4568d8b418e8f37
Autor:
Fernando Maluf, Andrey Soares, Guilherme Avanço, Aline Lury Hada, Ana Paula Garcia Cardoso, Arie Carneiro, Daniel Herchenhorn, Denis Leonardo Fontes Jardim, Fabio Augusto Schutz, Fabio Roberto Kater, Felipe Moraes Toledo Pereira, Fernando Sabino Marques Monteiro, Igor Alexandre Protzner Morbeck, João Francisco Navarro Reolon, Karine Martins da Trindade, Livia Maria Querino da Silvo Andrade, Lucas Mendes Nogueira, Renato Furoni, Ricardo Azze Natel, Rodolfo Borges dos Reis, Rodrigo Nogueira Fogace, Vinicius Carrera Souza
Publikováno v:
International Brazilian Journal of Urology, Vol 47, Iss 2, Pp 359-373 (2021)
ABSTRACT Background: Non-metastatic castration resistant prostate cancer (M0 CRPC) has seen important developments in drugs and diagnostic tools in the last two years. New hormonal agents have demonstrated improvement in metastasis free survival in M
Externí odkaz:
https://doaj.org/article/71c2709fc76e4b5fb64f15a3274c9006
Autor:
Gustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, Vinicius Carrera Souza, Suelen Patricia dos Santos Martins, Fábio Peixoto, Oren Smaletz, Fábio Schutz, Daniel Herchenhorn, Telma Santos, Flavio Mavignier Carcano, David Queiroz Muniz, Paulo R. S. Nunes Filho, Facundo Zaffaroni, Carlos Barrios, André Fay
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Testosterone suppression is the standard treatment for advanced prostate cancer, and it is associated with side-effects that impair patients’ quality of life, like sexual dysfunction, osteoporosis, weight gain, and increased car
Externí odkaz:
https://doaj.org/article/cc80e2d601e94b1baf2980625067c4c9
Autor:
Denis L. Jardim, Adriano Gonçalves e Silva, Alexandre Saad Fere Lima Pompeo, Alvaro Sadek Sarkis, Ana Paula Garcia Cardoso, Andre Deeke Sasse, Andre Poisl Fay, Andrey Soares, Antonio Carlos Lima Pompeo, Arie Carneiro, Ariel Galapo Kann, Camilla Fogassa, Celso Heitor De Freitas, Daher Cezar Chade, Daniel Herchenhorn, Daniel Vargas Pivato De Almeida, Diogo Augusto Rodrigues Da Rosa, Evanius Garcia Wiermann, Fabio Augusto Barros Schutz, Fabio Roberto Kater, Fernando De Moura, Fernando Korkes, Fernando Meyer, Fernando Nunes Galvao De Oliveira, Fernando Sabino, Gilberto Laurino Almeida, Guilherme Avanço, Gustavo Cardoso Guimaraes, Gustavo Caserta Lemos, Gustavo Franco Carvalhal, Hanna Kim, Igor Protzner Morbeck, Joao Carlos Campagnari, Jose Augusto Rinck, José Ricardo Tuma Da Ponte, Karine Martins Da Trindade, Leonardo Atem, Leonardo Borges, Lucas Mendes Nogueira, Lucas Teixeira e Aguiar Batista, Manuel Caitano Maia, Marcus Vinicius Sadi, Maria Alzira Almeida Rocha, Murilo De Almeida Luz, Oren Smaletz, Paulo Sergio Moraes Lages, Raquel Midori Koga Matuda, Rodolfo Borges Dos Reis, Rodrigo Frota Indio, Roni De Carvalho Fernandes, Sandro Roberto Cavallero, Vinicius Carrera Souza, Wilson Busato, Wladimir Alfer, Fernando Maluf
Publikováno v:
Clinical Genitourinary Cancer. 21:e58-e69
Non-metastatic, castration-resistant prostate cancer (nmCRPC) is an important clinical stage of prostate cancer, prior to morbidity and mortality from clinical metastases. In particular, the introduction of novel androgen-receptor signaling inhibitor
Autor:
Gabriela Dombrowski, Laura Fernandes Ferreira Dalcin, Francisco Assis Coelho, Patricia Massucheto Ledesma, Daniel Herchenhorn
Publikováno v:
International Journal of Otolaryngology and Head & Neck Surgery. 12:8-20